Indoxyl sulfate (IS), one of the uremic toxins, is regarded to have a substantial role in the progression of chronic kidney disease (CKD). Epithelial-to-mesenchymal transition (EMT) and apoptosis of renal tubular cells are known to be the critical mechanisms of the development and aggravation of CKD. We investigated the effect of IS on EMT and apoptosis in renal proximal tubular cells, NRK-52E cells. IS significantly inhibited cell proliferation and induced cell migration with a morphological transition from cuboidal epithelial cells to spindle-shaped scattered fibroblast-like cells. IS downregulated the expressions of zonula occluden-1 and E-cadherin, whereas upregulated a-SMA expression at 48 h, which was blocked by a pretreatment of the organic anion transporter, probenecid. IS also induced apoptosis of NRK cells from a concentration of 25 mg/ml with an activation of ERK1/2 and p38 MAP kinase (MAPK). Pretreatment of ERK1/2 or p38 MAPK inhibitors, PD98059 or SB203580, resulted in no significant effect on IS-induced EMT, whereas it ameliorated IS-induced apoptosis of NRK cells. These findings suggested phenotypic transition and apoptosis as potential mechanisms of IS-induced renal damage and the differential role of MAPK activation in IS-induced EMT and apoptosis of renal tubular cells. KEYWORDS: apoptosis; chronic kidney disease; epithelial-to-mesenchymal transition; indoxyl sulfate; MAPKinase Indoxyl sulfate (IS) is one of the protein-bound uremic solutes derived from tryptophan, which is converted to indole and subsequently undergoes sulfate conjugation in hepatocytes to form IS.1 It is taken by organic anion transporters (OATs) at the basolateral membrane of proximal tubular cells, and excreted mostly into urine through tubular secretion.2 Therefore, IS accumulates in patients with chronic kidney disease (CKD), 3 demonstrated as an increase in serum level and positive immunostaining area of IS in the kidneys. 4 Although IS is regarded as a marker of renal dysfunction, recent data have revealed that IS also has a substantial role in the progression of CKD.5 Indole, the precursor of IS, caused glomerular sclerosis in uremic rats, 6 and oral administration of IS increased serum creatinine and decreased inulin clearance in uremic rats.3 In a clinical study, patients with urinary IS levels 490 mg/day showed faster progression rate of CKD than did those with urinary IS o30 mg/day.7 Furthermore, the administration of oral adsorbent of IS resulted in a decrease in glomerular sclerosis and interstitial fibrosis in uremic rats associated with a decrease in plasma and urinary IS levels.3 Lowering IS also resulted in an improvement of renal function and a delay in the initiation of dialysis in CKD patients. 8 In a multicenter, randomized clinical study, Schulman et al 9 showed that an administration of AST-120, oral adsorbent of IS, ameliorated uremic symptoms in a dose-dependent manner with a decrease in serum IS and a stable maintenance of serum creatinine. The mechanism of IS-induced renal progression has been expla...
The CD4+CD25+ T regulatory cells (Tregs) play an important role in immune tolerance in experimental transplantation but the clinical significance of circulating Tregs in the peripheral blood is undetermined. In 50 kidney transplant (KT) recipients, 29 healthy controls and 32 liver transplant (LT) recipients, the frequency of Tregs was measured with flow cytometry before and after transplantation. In the KT recipients, IL-10 secretion was measured with an enzyme-linked immunospot (ELISPOT) assay. The median frequency of circulating Tregs before KT was similar to that in healthy controls but significantly lower than that in LT patients before transplantation. The frequency of Tregs was significantly decreased in patients with subclinical acute rejection compared with those without subclinical acute rejection. Calcineurin inhibitors (CNIs) and anti-CD25 antibody decreased the frequency of Tregs but mTOR inhibitor did not. The frequency of donor-specific IL-10 secreting cells did not correlate with the number of Tregs. The frequency of circulating Tregs in KT recipients is strongly affected by CNIs and anti-CD25 antibody, and a low frequency of Tregs is associated with subclinical acute rejection during the early posttransplant period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.